Novakand Pharma AB (publ) (FRA:3EE0)
Germany · Delayed Price · Currency is EUR 0.0001
0.00 (0.00%)
At close: Dec 19, 2025
Novakand Pharma AB Market Cap
Novakand Pharma AB has a market cap or net worth of €1.7 million as of December 22, 2025. Its market cap has decreased by -84.04% in one year.
Market Cap
1.70M
Enterprise Value
-344.91K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since February 28, 2011, Novakand Pharma AB's market cap has decreased from 10.30M to 1.70M, a decrease of -83.47%. That is a compound annual growth rate of -11.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.70M | -85.27% |
| Dec 30, 2024 | 11.57M | -65.19% |
| Dec 29, 2023 | 33.23M | 119.15% |
| Dec 30, 2022 | 15.16M | -54.88% |
| Dec 30, 2021 | 33.60M | -52.49% |
| Dec 30, 2020 | 70.73M | 666.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |